GU Cancer Clinical Trials

DISCLAIMER: All content found on cua.org is provided for information and education purposes. The medical information and clinical trials information is not intended to substitute for the advice of a physician, nor is it intended to provide legal advice. You should always consult your doctor for specific information on personal health matters, or other relevant professionals to ensure that your own circumstances are considered.

The CUA is not responsible in any manner for direct, indirect, special or consequential damages caused and/or arising from your use of cua.org.

Subspecialty
Prostate | ON | Recruiting
iSMART
Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer (iSMART)
Danny Vesprini
Start Date: March 1, 2024

NCT #: NCT05600400

SPONSOR: Sunnybrook Health Sciences Centre

INFO: https://clinicaltrials.gov/study/NCT05600400

CONTACT: Danny Vesprini
416-480-6100 x 4806; Danny.Vesprini@sunnybrook.ca

Other Canadian Centers:

1. Sunnybrook Health Sciences Centre (Toronto).

Prostate | BC | Recruiting
BrachyTRACKS
Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer (BrachyTRACKS)
Juanita M. Crook
Start Date: February 1, 2024

NCT #: NCT06200974

SPONSOR: British Columbia Cancer Agency

INFO: https://clinicaltrials.gov/study/NCT06200974

CONTACT: Juanita M. Crook

 

jcrook@bccancer.bc.ca; 250-712-3958

Other Canadian Centers:

 

1. British Columbia Cancer Center for Southern Interior (Kelowna)

Prostate | QC | Recruiting
PSMACare
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC (PSMACare)
Start Date: January 3, 2024

NCT #: NCT05849298

SPONSOR: Novartis Pharmaceuticals

INFO: https://clinicaltrials.gov/study/NCT05849298

CONTACT: novartis.email@novartis.com; 1-888-669-6682

Other Canadian Centres:

1. Centre hospitalier de l'Université de Montréal | CHUM (Montreal)                         
2. Jewish General Hospital (Montreal)

Prostate | AB | Recruiting
P-GAP
PSMA-Guided Ablation of the Prostate (P-GAP)
Alexander Tamm
Start Date: January 2, 2024

NCT #: NCT06003556

SPONSOR: University of Alberta

INFO: https://clinicaltrials.gov/study/NCT06003556

CONTACT: Adam Kinnaird
780-5800 x 321;  ask@ualberta.ca

Other Canadian Centres:

 

1. Royal Alexandra Hospital (Edmonton) 2. University of Alberta (Edmonton)

Prostate | ON | Recruiting
DESTINATION-MRL
De-escalated Dose SBRT in Localized Prostate Cancer (DESTINATION-MRL)
Danny Vesprini
Start Date: December 11, 2023

NCT #: NCT06177093

SPONSOR: Sunnybrook Health Sciences Centre

INFO: https://clinicaltrials.gov/study/NCT06177093

CONTACT: Danny Vesprini

416-480-6100 x 4806; Danny.Vesprini@sunnybrook.ca

Other Canadian Centers:

 

1. Sunnybrook Health Sciences Centre (Toronto).

Renal | BC, QC | Recruiting
AT-1501-K102, 2021-003830-36 ( EudraCT Number )
Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
Start Date: December 11, 2023

NCT #: NCT05027906

SPONSOR: Eledon Pharmaceuticals

INFO: https://clinicaltrials.gov/study/NCT05027906

CONTACT: 949-238-8090                      

clinicaltrials@eledon.com

Other Canadian Centres:

1. Providence Health Care - St. Paul's Hospital (Vancouver).                                          

2. Vancouver General Hospital (Vancouver)                                                                                    

3. McGill University Health Centre (Montreal) 

Prostate | ON | Recruiting
DEFINE & 20220698-01H
Dose Escalation For INtraprostatic LEsions (DEFINE)
Start Date: November 23, 2023

NCT #: NCT05851547

SPONSOR: Ottawa Hospital Research Institute

INFO: https://clinicaltrials.gov/study/NCT05851547

CONTACT: Scott Grimes

613-737-7700 x 70523; sgrimes@ohri.ca

Other Canadian Centres:

1. The Ottawa Hospital Cancer Centre

Prostate | ON | Recruiting
EvoPAR-PR01
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents (EvoPAR-PR01)
Dr. Kim Nguyen Chi, Dr. Arun Azad
Start Date: November 21, 2023

NCT #: NCT06120491

SPONSOR: AstraZeneca

INFO: https://clinicaltrials.gov/study/NCT06120491

CONTACT: Dr. Kim Nguyen Chi (BC Cancer Canada) 
Dr. Arun Azad (Peter MacCallum Cancer Centre, Australia) 

1-877-240-9479

 

Renal | ON | Recruiting
HALLMARK
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients (HALLMARK)
Sunita Singh
Start Date: October 24, 2023

NCT #: NCT05938712

SPONSOR: University Health Network, Toronto

INFO: https://clinicaltrials.gov/study/NCT05938712

CONTACT: Vesta Lai: vesta.lai@uhn.ca                

416-340-4800 x 8508

Other Canadian Centres:

1. Toronto General Hospital (Toronto)

Renal | NS | Not yet recruiting
QuitWIT
Novel Cooling Device for the Elimination of Warm Ischemia During Renal Transplantation (QuitWIT)
Thomas Skinner
Start Date: October 1, 2023

NCT #: NCT05166460

SPONSOR: Thomas Skinner

INFO: https://clinicaltrials.gov/study/NCT05166460

CONTACT: tomaaskinner@gmail.com

Other Canadian Centres:

1. Queen Elizabeth ll Health Sciences Centre (Halifax)

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy